Cell DeathAntineoplastic Combined Chemotherapy ProtocolsT-Lymphocytes, CytotoxicCytotoxicity, ImmunologicChemotherapy, AdjuvantGranzymesApoptosisCytotoxicity Tests, ImmunologicKiller Cells, NaturalAntineoplastic AgentsPore Forming Cytotoxic ProteinsCause of DeathPerforinT-LymphocytesCisplatinCombined Modality TherapyDoxorubicinSpleenSerine EndopeptidasesCell SurvivalCyclophosphamideTreatment OutcomeHistocompatibility AntigensIsoantigensLymphocyte ActivationCells, CulturedCaspasesTime FactorsLymphocyte Culture Test, MixedCell Line, TumorCell LineMice, Inbred BALB CMice, Inbred C57BLEtoposideBreast NeoplasmsLymphocytesDeathAntibodies, MonoclonalIctaluridaeAntigens, CD56Immunity, CellularMast-Cell SarcomaInterleukin-2Neoadjuvant TherapySurvival AnalysisFlow CytometryAntigens, Differentiation, T-LymphocyteNeoplasmsDisease-Free SurvivalAntigens, CD8Lung NeoplasmsPrognosisSurvival RateNeoplasms, ExperimentalMice, Inbred StrainsNeoplasm StagingLymphomaCaspase 3Mice, Inbred CBAProto-Oncogene Proteins c-bcl-2NecrosisDrug Resistance, NeoplasmDrug Administration ScheduleT-Lymphocytes, Helper-InducerAntigens, CD3PaclitaxelMethotrexateCD8-Positive T-LymphocytesMembrane GlycoproteinsKiller Cells, Lymphokine-ActivatedDose-Response Relationship, DrugAntineoplastic Agents, PhytogenicTumor Cells, CulturedLeukocyte CountDNA FragmentationAntibody-Dependent Cell CytotoxicitySignal TransductionVinblastineCarboplatinSarcoma, ExperimentalMitochondriaMolecular Sequence DataTaxoidsT-Lymphocytes, RegulatoryAntimetabolites, AntineoplasticH-2 AntigensAutophagyDrug Screening Assays, AntitumorNeoplasm Recurrence, LocalInduction ChemotherapyAntigens, SurfaceFollow-Up StudiesAntineoplastic Agents, AlkylatingDeoxycytidineOrganoplatinum Compoundsbcl-2-Associated X ProteinIn Situ Nick-End LabelingLymphocytes, Tumor-InfiltratingCytotoxinsIfosfamide